Repros Therapeutics Inc (NASDAQ:RPRX)

8.96
Delayed Data
As of 11:47am ET
 -0.20 / -2.18%
Today’s Change
5.92
Today|||52-Week Range
22.55
-10.13%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2010

2011

2012

2013
Operating ActivitiesNet Income / Starting Line-4.8M-12.5M-18.2M-27.7M
 
 
 
 
 
Depreciation87.0K115.0K145.0K257.0K
 
 
 
 
 
Total Other Cash Flow447.0K2.3M2.8M3.2M
 
 
 
 
 
Funds From Operations-4.2M-10.1M-15.2M-24.3M
 
 
 
 
 
Funds From/For Other Operating Expenses718.0K-329.0K-1.7M142.0K
 
 
 
 
 
Net Cash Flow - Operating Activities-5.0M-9.8M-13.5M-24.4M
 
 
 
 
 
 
InvestingCapital Expenditures-7.0K-15.0K-30.0K-911.0K
 
 
 
 
 
Net Cash Flow Investing-371.0K-335.0K-608.0K-911.0K
 
 
 
 
 
 
FinancingShort Term Borrowings0.000.000.000.00--
Long Term Borrowings0.000.000.000.00--
Long Term Debt Reduction0.000.000.000.00--
Net Proceeds Stock Sale6.4M11.7M33.8M77.0M
 
 
 
 
 
Common Preferred Redeemed0.000.000.000.00--
Common Dividends0.000.000.000.00--
Cash Dividends Paid - Total0.000.000.000.00--
Other Sources - Financing0.000.000.000.00--
Other Uses - Financing0.000.000.000.00--
Net Cash Flow - Financing6.4M11.7M33.8M77.0M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash----0.000.00--
 
Net Change In Cash1.1M1.6M19.6M51.6M
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account